Skip to content

Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04629989
Enrollment
27
Registered
2020-11-16
Start date
2020-11-13
Completion date
2021-03-05
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Hypoxemia

Keywords

Double-Trunk Mask, Surgical Mask

Brief summary

This study will compare the impact of two systems above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19. The two systems are the Surgical Mask (SM) and the Double-Trunk Mask (DTM).

Detailed description

Hospitalized patients with COVID-19 typically present with hypoxemia. In some patients, hypoxemia can be corrected with low flow nasal cannula. When placed above nasal cannula, some systems have demonstrated their interest in improving the performance of patient's oxygen delivery. For example, two recent studies have shown that adding a Double-Trunk Mask (DTM) or Surgical Mask (SM) above nasal cannula has the potential to improve the PaO2 despite no change in oxygen output (Duprez et al., J Clin Monit Comput 2020; Montiel et al., Ann Intensive Care 2020). However, there is no study comparing the relative effectiveness of these 2 systems.

Interventions

The standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.

The Double-Trunk Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.

The Surgical Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COVID-19 positive * SpO2 between 92 and 96% with low-flow oxygen therapy * Oxygen output at baseline between 3 and 7 L/min.

Exclusion criteria

* Pulmonary disease with hypercapnia * Confusion * Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding disorder)

Design outcomes

Primary

MeasureTime frameDescription
Changes in PaO2At baseline and 30 minutes after wearing the randomized oxygen delivery systemOxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system

Secondary

MeasureTime frameDescription
Change in PaCO2At baseline and 30 minutes after wearing the randomized oxygen delivery systemCarbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.
Change in pHAt baseline and 30 minutes after wearing the randomized oxygen delivery systemPotential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.
Change in respiratory rateAt baseline, 30 minutes and 60 minutes after wearing the randomized oxygen delivery systemRespiratory rate is measured during one minute by visual inspection.
Change in dyspneaAt baseline and 60 minutes after wearing the randomized oxygen delivery systemDyspnea is rated with a visual analogic scale (0 to 100mm).
Change in O2 outputAt 30 minutes and 60 minutes after wearing the randomized oxygen delivery systemThe O2 output will be adjusted to recover the baseline SpO2 reading. The O2 output will be read from the position of the ball inside the flowmeter.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026